Patients whose tumors are driven by genetic mutations by cancer type 2016

The data shows the percentage of patients as of 2016 whose tumors are driven by certain genetic mutations, and thus may benefit from personalized medical treatment and specific drug therapies. Of patients diagnosed with lung cancer, 41% had tumors that are driven or caused by genetic mutation, while of patients diagnosed with thyroid cancer, 56% had tumors driven by genetic mutation.